nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—ANKK1—nicotine dependence	0.815	1	CbGaD
Ruxolitinib—PRKG2—cardiovascular system—nicotine dependence	0.00398	0.0413	CbGeAlD
Ruxolitinib—RPS6KA6—cardiovascular system—nicotine dependence	0.00357	0.037	CbGeAlD
Ruxolitinib—PLK3—cardiovascular system—nicotine dependence	0.00298	0.0309	CbGeAlD
Ruxolitinib—Night sweats—Varenicline—nicotine dependence	0.00246	0.181	CcSEcCtD
Ruxolitinib—JAK1—cardiovascular system—nicotine dependence	0.00228	0.0237	CbGeAlD
Ruxolitinib—HIPK2—cardiovascular system—nicotine dependence	0.00213	0.0221	CbGeAlD
Ruxolitinib—DAPK3—cardiovascular system—nicotine dependence	0.00205	0.0213	CbGeAlD
Ruxolitinib—ROCK1—cardiovascular system—nicotine dependence	0.00197	0.0204	CbGeAlD
Ruxolitinib—PRKG2—brain—nicotine dependence	0.00195	0.0203	CbGeAlD
Ruxolitinib—DYRK1A—cardiovascular system—nicotine dependence	0.00192	0.0199	CbGeAlD
Ruxolitinib—BMPR2—cardiovascular system—nicotine dependence	0.00191	0.0198	CbGeAlD
Ruxolitinib—GRK1—brain—nicotine dependence	0.00186	0.0193	CbGeAlD
Ruxolitinib—PRKCE—brain—nicotine dependence	0.00182	0.0189	CbGeAlD
Ruxolitinib—JAK1—midbrain—nicotine dependence	0.00178	0.0185	CbGeAlD
Ruxolitinib—DCLK1—midbrain—nicotine dependence	0.00178	0.0185	CbGeAlD
Ruxolitinib—PLK1—brain—nicotine dependence	0.00175	0.0182	CbGeAlD
Ruxolitinib—RPS6KA6—brain—nicotine dependence	0.00175	0.0182	CbGeAlD
Ruxolitinib—MAST1—brain—nicotine dependence	0.00175	0.0182	CbGeAlD
Ruxolitinib—CAMK2G—cardiovascular system—nicotine dependence	0.00171	0.0177	CbGeAlD
Ruxolitinib—DAPK2—midbrain—nicotine dependence	0.0017	0.0177	CbGeAlD
Ruxolitinib—DCLK3—brain—nicotine dependence	0.00166	0.0172	CbGeAlD
Ruxolitinib—DAPK3—midbrain—nicotine dependence	0.0016	0.0166	CbGeAlD
Ruxolitinib—TYK2—cardiovascular system—nicotine dependence	0.00151	0.0157	CbGeAlD
Ruxolitinib—BMPR2—midbrain—nicotine dependence	0.00149	0.0155	CbGeAlD
Ruxolitinib—MKNK2—cardiovascular system—nicotine dependence	0.00149	0.0155	CbGeAlD
Ruxolitinib—PLK3—brain—nicotine dependence	0.00146	0.0152	CbGeAlD
Ruxolitinib—LTK—brain—nicotine dependence	0.00141	0.0146	CbGeAlD
Ruxolitinib—JAK2—cardiovascular system—nicotine dependence	0.00137	0.0143	CbGeAlD
Ruxolitinib—CAMK1—brain—nicotine dependence	0.00137	0.0142	CbGeAlD
Ruxolitinib—CAMK2G—midbrain—nicotine dependence	0.00134	0.0139	CbGeAlD
Ruxolitinib—BMP2K—midbrain—nicotine dependence	0.00134	0.0139	CbGeAlD
Ruxolitinib—MARK2—brain—nicotine dependence	0.00133	0.0138	CbGeAlD
Ruxolitinib—MAP3K3—cardiovascular system—nicotine dependence	0.00132	0.0137	CbGeAlD
Ruxolitinib—LRRK2—midbrain—nicotine dependence	0.00132	0.0137	CbGeAlD
Ruxolitinib—TAOK2—brain—nicotine dependence	0.00123	0.0127	CbGeAlD
Ruxolitinib—TAOK3—cardiovascular system—nicotine dependence	0.00121	0.0125	CbGeAlD
Ruxolitinib—MAP3K7—midbrain—nicotine dependence	0.0012	0.0125	CbGeAlD
Ruxolitinib—TYK2—midbrain—nicotine dependence	0.00118	0.0122	CbGeAlD
Ruxolitinib—IRAK1—midbrain—nicotine dependence	0.00116	0.0121	CbGeAlD
Ruxolitinib—MKNK2—midbrain—nicotine dependence	0.00116	0.0121	CbGeAlD
Ruxolitinib—RET—midbrain—nicotine dependence	0.00114	0.0118	CbGeAlD
Ruxolitinib—JAK3—brain—nicotine dependence	0.00113	0.0117	CbGeAlD
Ruxolitinib—DCLK1—brain—nicotine dependence	0.00112	0.0116	CbGeAlD
Ruxolitinib—JAK1—brain—nicotine dependence	0.00112	0.0116	CbGeAlD
Ruxolitinib—PLK4—brain—nicotine dependence	0.00111	0.0116	CbGeAlD
Ruxolitinib—CAMK1D—brain—nicotine dependence	0.00109	0.0114	CbGeAlD
Ruxolitinib—PHKG2—brain—nicotine dependence	0.00109	0.0113	CbGeAlD
Ruxolitinib—DAPK2—brain—nicotine dependence	0.00107	0.0111	CbGeAlD
Ruxolitinib—ROCK1—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00107	0.0142	CbGpPWpGaD
Ruxolitinib—STK16—brain—nicotine dependence	0.00105	0.0109	CbGeAlD
Ruxolitinib—HIPK2—brain—nicotine dependence	0.00105	0.0109	CbGeAlD
Ruxolitinib—RPS6KA6—Neuronal System—CHRNA6—nicotine dependence	0.00104	0.0138	CbGpPWpGaD
Ruxolitinib—MAP3K3—midbrain—nicotine dependence	0.00103	0.0107	CbGeAlD
Ruxolitinib—MAP3K19—brain—nicotine dependence	0.00102	0.0106	CbGeAlD
Ruxolitinib—DAPK3—brain—nicotine dependence	0.00101	0.0104	CbGeAlD
Ruxolitinib—CLK2—brain—nicotine dependence	0.000996	0.0103	CbGeAlD
Ruxolitinib—CAMK2G—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.000995	0.0132	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000982	0.013	CbGpPWpGaD
Ruxolitinib—ROCK1—brain—nicotine dependence	0.000965	0.01	CbGeAlD
Ruxolitinib—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.000964	0.0709	CcSEcCtD
Ruxolitinib—RPS6KA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000949	0.0126	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.000944	0.0125	CbGpPWpGaD
Ruxolitinib—TAOK3—midbrain—nicotine dependence	0.000943	0.00979	CbGeAlD
Ruxolitinib—RPS6KA6—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000942	0.0125	CbGpPWpGaD
Ruxolitinib—DYRK1A—brain—nicotine dependence	0.000941	0.00977	CbGeAlD
Ruxolitinib—BMPR2—brain—nicotine dependence	0.000937	0.00973	CbGeAlD
Ruxolitinib—NUAK2—brain—nicotine dependence	0.000896	0.0093	CbGeAlD
Ruxolitinib—RPS6KA6—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000875	0.0116	CbGpPWpGaD
Ruxolitinib—PRKCE—Fcgamma receptor (FCGR) dependent phagocytosis—WASF2—nicotine dependence	0.000874	0.0116	CbGpPWpGaD
Ruxolitinib—CAMK2G—brain—nicotine dependence	0.000839	0.00871	CbGeAlD
Ruxolitinib—BMP2K—brain—nicotine dependence	0.000839	0.00871	CbGeAlD
Ruxolitinib—PRKCE—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—nicotine dependence	0.000838	0.0111	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000836	0.0111	CbGpPWpGaD
Ruxolitinib—LRRK2—brain—nicotine dependence	0.000831	0.00863	CbGeAlD
Ruxolitinib—RET—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000822	0.0109	CbGpPWpGaD
Ruxolitinib—JAK3—IL4-mediated signaling events—OPRM1—nicotine dependence	0.000789	0.0105	CbGpPWpGaD
Ruxolitinib—IRAK1—p75 NTR receptor-mediated signalling—FGD1—nicotine dependence	0.000768	0.0102	CbGpPWpGaD
Ruxolitinib—MAP3K2—brain—nicotine dependence	0.000762	0.00791	CbGeAlD
Ruxolitinib—RPS6KA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000759	0.0101	CbGpPWpGaD
Ruxolitinib—Weight increased—Varenicline—nicotine dependence	0.000759	0.0558	CcSEcCtD
Ruxolitinib—MAP3K7—brain—nicotine dependence	0.000755	0.00783	CbGeAlD
Ruxolitinib—RPS6KA6—Neuronal System—GABRA4—nicotine dependence	0.000753	0.00999	CbGpPWpGaD
Ruxolitinib—CAMK2G—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.000748	0.00993	CbGpPWpGaD
Ruxolitinib—Infestation NOS—Varenicline—nicotine dependence	0.000743	0.0547	CcSEcCtD
Ruxolitinib—Infestation—Varenicline—nicotine dependence	0.000743	0.0547	CcSEcCtD
Ruxolitinib—TYK2—brain—nicotine dependence	0.000741	0.00769	CbGeAlD
Ruxolitinib—MAP3K2—ErbB1 downstream signaling—WASF2—nicotine dependence	0.000739	0.00981	CbGpPWpGaD
Ruxolitinib—MKNK2—brain—nicotine dependence	0.000731	0.00759	CbGeAlD
Ruxolitinib—IRAK1—brain—nicotine dependence	0.000731	0.00759	CbGeAlD
Ruxolitinib—RPS6KA6—Neuronal System—CHRNB4—nicotine dependence	0.000721	0.00957	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000714	0.00947	CbGpPWpGaD
Ruxolitinib—RET—brain—nicotine dependence	0.000713	0.00741	CbGeAlD
Ruxolitinib—CAMK2G—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000709	0.00941	CbGpPWpGaD
Ruxolitinib—Hepatobiliary disease—Varenicline—nicotine dependence	0.000703	0.0517	CcSEcCtD
Ruxolitinib—Epistaxis—Varenicline—nicotine dependence	0.000701	0.0516	CcSEcCtD
Ruxolitinib—CAMK2G—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.000682	0.00905	CbGpPWpGaD
Ruxolitinib—JAK1—IL4-mediated signaling events—OPRM1—nicotine dependence	0.000679	0.00901	CbGpPWpGaD
Ruxolitinib—JAK2—brain—nicotine dependence	0.000674	0.007	CbGeAlD
Ruxolitinib—RPS6KA6—Neuronal System—CHRNA5—nicotine dependence	0.000671	0.0089	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.000654	0.00868	CbGpPWpGaD
Ruxolitinib—MAP3K3—brain—nicotine dependence	0.00065	0.00675	CbGeAlD
Ruxolitinib—PRKG2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000646	0.00857	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000628	0.00834	CbGpPWpGaD
Ruxolitinib—PRKCE—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.000618	0.0082	CbGpPWpGaD
Ruxolitinib—ROCK1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.000616	0.00817	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.000608	0.00807	CbGpPWpGaD
Ruxolitinib—TAOK3—brain—nicotine dependence	0.000592	0.00615	CbGeAlD
Ruxolitinib—Malnutrition—Varenicline—nicotine dependence	0.000581	0.0427	CcSEcCtD
Ruxolitinib—CAMK2G—Neuronal System—CHRNB3—nicotine dependence	0.000573	0.00761	CbGpPWpGaD
Ruxolitinib—Flatulence—Varenicline—nicotine dependence	0.000572	0.0421	CcSEcCtD
Ruxolitinib—RPS6KA6—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000571	0.00757	CbGpPWpGaD
Ruxolitinib—DYRK1A—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000549	0.00729	CbGpPWpGaD
Ruxolitinib—RET—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000549	0.00728	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Neuronal System—CHRNA3—nicotine dependence	0.000547	0.00726	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neuronal System—CHRNA6—nicotine dependence	0.000543	0.00721	CbGpPWpGaD
Ruxolitinib—Anaemia—Varenicline—nicotine dependence	0.000537	0.0395	CcSEcCtD
Ruxolitinib—CAMK2G—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000513	0.0068	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by NGF—FGD1—nicotine dependence	0.000512	0.0068	CbGpPWpGaD
Ruxolitinib—JAK1—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.000508	0.00674	CbGpPWpGaD
Ruxolitinib—ROCK1—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.0005	0.00663	CbGpPWpGaD
Ruxolitinib—RET—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000498	0.00661	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000496	0.00658	CbGpPWpGaD
Ruxolitinib—CAMK2G—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000492	0.00652	CbGpPWpGaD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000491	0.0361	CcSEcCtD
Ruxolitinib—JAK1—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.000487	0.00646	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Neuronal System—CHRNB2—nicotine dependence	0.000481	0.00639	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by VEGF—WASF2—nicotine dependence	0.00048	0.00636	CbGpPWpGaD
Ruxolitinib—ROCK1—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.000479	0.00636	CbGpPWpGaD
Ruxolitinib—PRKG2—Circadian rythm related genes—DRD2—nicotine dependence	0.000478	0.00634	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by VEGF—WASF2—nicotine dependence	0.000472	0.00626	CbGpPWpGaD
Ruxolitinib—Infection—Varenicline—nicotine dependence	0.000471	0.0346	CcSEcCtD
Ruxolitinib—Nervous system disorder—Varenicline—nicotine dependence	0.000465	0.0342	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Varenicline—nicotine dependence	0.000464	0.0341	CcSEcCtD
Ruxolitinib—Skin disorder—Varenicline—nicotine dependence	0.00046	0.0339	CcSEcCtD
Ruxolitinib—JAK1—Signaling by VEGF—WASF1—nicotine dependence	0.00046	0.0061	CbGpPWpGaD
Ruxolitinib—CAMK2G—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000457	0.00606	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by VEGF—WASF1—nicotine dependence	0.000452	0.006	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Neuronal System—CHRNA4—nicotine dependence	0.000437	0.0058	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000436	0.00579	CbGpPWpGaD
Ruxolitinib—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000409	0.0301	CcSEcCtD
Ruxolitinib—Fatigue—Varenicline—nicotine dependence	0.000409	0.0301	CcSEcCtD
Ruxolitinib—DYRK1A—Circadian rythm related genes—DRD2—nicotine dependence	0.000406	0.00539	CbGpPWpGaD
Ruxolitinib—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000406	0.00538	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000396	0.00526	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neuronal System—GABRA4—nicotine dependence	0.000393	0.00521	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—CCAR1—nicotine dependence	0.000391	0.00518	CbGpPWpGaD
Ruxolitinib—ROCK1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.000383	0.00509	CbGpPWpGaD
Ruxolitinib—JAK2—IL4-mediated signaling events—OPRM1—nicotine dependence	0.00038	0.00504	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neuronal System—CHRNB4—nicotine dependence	0.000377	0.005	CbGpPWpGaD
Ruxolitinib—TYK2—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.000375	0.00498	CbGpPWpGaD
Ruxolitinib—Body temperature increased—Varenicline—nicotine dependence	0.000375	0.0276	CcSEcCtD
Ruxolitinib—CAMK2G—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000373	0.00494	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—FGD1—nicotine dependence	0.000372	0.00493	CbGpPWpGaD
Ruxolitinib—ROCK1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000368	0.00488	CbGpPWpGaD
Ruxolitinib—MAP3K7—TCR Signaling Pathway—OPRM1—nicotine dependence	0.000361	0.00479	CbGpPWpGaD
Ruxolitinib—TYK2—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00036	0.00477	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by VEGF—WASF2—nicotine dependence	0.000354	0.0047	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neuronal System—CHRNA5—nicotine dependence	0.00035	0.00465	CbGpPWpGaD
Ruxolitinib—Asthenia—Varenicline—nicotine dependence	0.00034	0.025	CcSEcCtD
Ruxolitinib—TYK2—Signaling by VEGF—WASF1—nicotine dependence	0.000339	0.0045	CbGpPWpGaD
Ruxolitinib—Pruritus—Varenicline—nicotine dependence	0.000335	0.0247	CcSEcCtD
Ruxolitinib—CAMK2G—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000328	0.00435	CbGpPWpGaD
Ruxolitinib—Dizziness—Varenicline—nicotine dependence	0.000313	0.0231	CcSEcCtD
Ruxolitinib—CAMK2G—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000298	0.00395	CbGpPWpGaD
Ruxolitinib—Headache—Varenicline—nicotine dependence	0.000297	0.0218	CcSEcCtD
Ruxolitinib—CAMK2G—Neuronal System—CHRNA3—nicotine dependence	0.000285	0.00379	CbGpPWpGaD
Ruxolitinib—JAK2—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.000284	0.00377	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—FGD1—nicotine dependence	0.000283	0.00375	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—FGD1—nicotine dependence	0.000274	0.00364	CbGpPWpGaD
Ruxolitinib—JAK2—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.000273	0.00362	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by VEGF—WASF2—nicotine dependence	0.000268	0.00356	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000261	0.00347	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by VEGF—WASF1—nicotine dependence	0.000257	0.00341	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—TAS2R16—nicotine dependence	0.000254	0.00337	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neuronal System—CHRNB2—nicotine dependence	0.000251	0.00334	CbGpPWpGaD
Ruxolitinib—JAK2—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.000251	0.00333	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000239	0.00317	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—TAS2R16—nicotine dependence	0.000237	0.00315	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—AKR1B10—nicotine dependence	0.000236	0.00314	CbGpPWpGaD
Ruxolitinib—CAMK2G—Neuronal System—CHRNA4—nicotine dependence	0.000228	0.00303	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000221	0.00293	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TAS2R16—nicotine dependence	0.000216	0.00286	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—AKR1B10—nicotine dependence	0.000214	0.00284	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—FGD1—nicotine dependence	0.000208	0.00276	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—FGD1—nicotine dependence	0.000205	0.00272	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—TAS2R16—nicotine dependence	0.0002	0.00266	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—FGD1—nicotine dependence	0.000199	0.00264	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—CYP2A7—nicotine dependence	0.000196	0.0026	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00019	0.00252	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—FGD1—nicotine dependence	0.000187	0.00249	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000187	0.00248	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—FGD1—nicotine dependence	0.000186	0.00247	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—WASF2—nicotine dependence	0.000182	0.00241	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—AKR1B10—nicotine dependence	0.000176	0.00234	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—WASF1—nicotine dependence	0.000174	0.00231	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—FGD1—nicotine dependence	0.000173	0.0023	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000172	0.00229	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000169	0.00225	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—FGD1—nicotine dependence	0.000169	0.00225	CbGpPWpGaD
Ruxolitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000168	0.00223	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—CYP2A7—nicotine dependence	0.000166	0.00221	CbGpPWpGaD
Ruxolitinib—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000166	0.00221	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—AKR1B10—nicotine dependence	0.000165	0.0022	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—FGD1—nicotine dependence	0.000157	0.00209	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—AKR1B10—nicotine dependence	0.00015	0.00199	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000149	0.00198	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000146	0.00194	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TAS2R16—nicotine dependence	0.00014	0.00186	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—AKR1B10—nicotine dependence	0.000139	0.00184	CbGpPWpGaD
Ruxolitinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000137	0.00181	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—FGD1—nicotine dependence	0.000135	0.00179	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—FGD1—nicotine dependence	0.000133	0.00176	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—WASF2—nicotine dependence	0.000132	0.00175	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000127	0.00169	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—WASF1—nicotine dependence	0.000127	0.00168	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—WASF2—nicotine dependence	0.000124	0.00165	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—WASF1—nicotine dependence	0.000119	0.00158	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TAS2R16—nicotine dependence	0.000118	0.00157	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—WASF2—nicotine dependence	0.000117	0.00155	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—WASF1—nicotine dependence	0.000112	0.00148	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—OPRM1—nicotine dependence	0.00011	0.00146	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—FGD1—nicotine dependence	0.00011	0.00146	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—OPRM1—nicotine dependence	0.000107	0.00142	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000106	0.00141	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—WASF2—nicotine dependence	0.000106	0.0014	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—WASF2—nicotine dependence	0.000105	0.0014	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000102	0.00135	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—WASF1—nicotine dependence	0.000102	0.00135	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—WASF1—nicotine dependence	0.000101	0.00134	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—AKR1B10—nicotine dependence	0.000101	0.00134	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—OPRM1—nicotine dependence	0.000101	0.00134	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—WASF2—nicotine dependence	0.0001	0.00133	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TAS2R16—nicotine dependence	0.0001	0.00133	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—OPRM1—nicotine dependence	0.0001	0.00133	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—FGD1—nicotine dependence	9.98e-05	0.00132	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—WASF2—nicotine dependence	9.74e-05	0.00129	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—AKR1B10—nicotine dependence	9.72e-05	0.00129	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—WASF2—nicotine dependence	9.7e-05	0.00129	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—TAS2R16—nicotine dependence	9.64e-05	0.00128	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—WASF1—nicotine dependence	9.62e-05	0.00128	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—WASF2—nicotine dependence	9.47e-05	0.00126	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—WASF2—nicotine dependence	9.45e-05	0.00125	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—WASF1—nicotine dependence	9.34e-05	0.00124	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—WASF1—nicotine dependence	9.3e-05	0.00123	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—OPRM1—nicotine dependence	9.3e-05	0.00123	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGD1—nicotine dependence	9.28e-05	0.00123	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—OPRM1—nicotine dependence	9.1e-05	0.00121	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—WASF1—nicotine dependence	9.08e-05	0.00121	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—WASF1—nicotine dependence	9.06e-05	0.0012	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—WASF2—nicotine dependence	8.94e-05	0.00119	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—WASF1—nicotine dependence	8.57e-05	0.00114	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—OPRM1—nicotine dependence	8.44e-05	0.00112	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—FGD1—nicotine dependence	8.33e-05	0.00111	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—AKR1B10—nicotine dependence	8.2e-05	0.00109	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—OPRM1—nicotine dependence	8e-05	0.00106	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGD1—nicotine dependence	7.99e-05	0.00106	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—DRD2—nicotine dependence	7.96e-05	0.00106	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—OPRM1—nicotine dependence	7.87e-05	0.00104	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGD1—nicotine dependence	7.85e-05	0.00104	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TAS2R16—nicotine dependence	7.74e-05	0.00103	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—DRD2—nicotine dependence	7.74e-05	0.00103	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	7.69e-05	0.00102	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—WASF2—nicotine dependence	7.69e-05	0.00102	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—FGD1—nicotine dependence	7.56e-05	0.001	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TAS2R16—nicotine dependence	7.51e-05	0.000997	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—AKR1B10—nicotine dependence	7.44e-05	0.000987	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—WASF2—nicotine dependence	7.38e-05	0.00098	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—WASF1—nicotine dependence	7.37e-05	0.000978	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TAS2R16—nicotine dependence	7.29e-05	0.000967	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—DRD2—nicotine dependence	7.28e-05	0.000965	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—OPRM1—nicotine dependence	7.26e-05	0.000964	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	7.25e-05	0.000962	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—DRD2—nicotine dependence	7.23e-05	0.00096	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	7.15e-05	0.000949	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—OPRM1—nicotine dependence	7.14e-05	0.000948	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—WASF1—nicotine dependence	7.08e-05	0.000939	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AKR1B10—nicotine dependence	7.05e-05	0.000936	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AKR1B10—nicotine dependence	6.94e-05	0.000921	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—WASF2—nicotine dependence	6.85e-05	0.000908	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—DRD2—nicotine dependence	6.72e-05	0.000892	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—DRD2—nicotine dependence	6.58e-05	0.000873	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—WASF1—nicotine dependence	6.56e-05	0.000871	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—DRD2—nicotine dependence	6.1e-05	0.00081	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGD1—nicotine dependence	6.07e-05	0.000806	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—OPRM1—nicotine dependence	5.91e-05	0.000784	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGD1—nicotine dependence	5.9e-05	0.000782	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—WASF2—nicotine dependence	5.85e-05	0.000776	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—DRD2—nicotine dependence	5.78e-05	0.000767	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—WASF2—nicotine dependence	5.78e-05	0.000767	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGD1—nicotine dependence	5.72e-05	0.000759	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TAS2R16—nicotine dependence	5.69e-05	0.000755	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—DRD2—nicotine dependence	5.69e-05	0.000755	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—WASF2—nicotine dependence	5.67e-05	0.000753	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—AKR1B10—nicotine dependence	5.64e-05	0.000748	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—WASF1—nicotine dependence	5.6e-05	0.000744	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—WASF1—nicotine dependence	5.54e-05	0.000735	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—WASF2—nicotine dependence	5.5e-05	0.00073	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—WASF1—nicotine dependence	5.44e-05	0.000722	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AKR1B10—nicotine dependence	5.36e-05	0.000712	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—OPRM1—nicotine dependence	5.36e-05	0.000711	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—WASF1—nicotine dependence	5.28e-05	0.0007	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—DRD2—nicotine dependence	5.25e-05	0.000697	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AKR1B10—nicotine dependence	5.21e-05	0.000691	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—DRD2—nicotine dependence	5.16e-05	0.000685	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AKR1B10—nicotine dependence	5.05e-05	0.00067	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—OPRM1—nicotine dependence	4.99e-05	0.000662	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—WASF2—nicotine dependence	4.97e-05	0.000659	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—WASF2—nicotine dependence	4.89e-05	0.000649	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—WASF1—nicotine dependence	4.76e-05	0.000632	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—WASF1—nicotine dependence	4.69e-05	0.000622	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—OPRM1—nicotine dependence	4.47e-05	0.000594	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGD1—nicotine dependence	4.47e-05	0.000593	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—WASF2—nicotine dependence	4.3e-05	0.000571	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—OPRM1—nicotine dependence	4.29e-05	0.000569	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—DRD2—nicotine dependence	4.27e-05	0.000567	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—OPRM1—nicotine dependence	4.22e-05	0.00056	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—WASF1—nicotine dependence	4.12e-05	0.000547	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—OPRM1—nicotine dependence	4.06e-05	0.000539	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AKR1B10—nicotine dependence	3.95e-05	0.000524	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—DRD2—nicotine dependence	3.88e-05	0.000514	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—WASF2—nicotine dependence	3.78e-05	0.000501	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—WASF2—nicotine dependence	3.67e-05	0.000487	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—WASF1—nicotine dependence	3.62e-05	0.000481	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—DRD2—nicotine dependence	3.61e-05	0.000478	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—WASF2—nicotine dependence	3.56e-05	0.000472	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—WASF1—nicotine dependence	3.52e-05	0.000467	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—WASF1—nicotine dependence	3.41e-05	0.000453	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—OPRM1—nicotine dependence	3.26e-05	0.000433	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—DRD2—nicotine dependence	3.23e-05	0.000429	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—OPRM1—nicotine dependence	3.17e-05	0.00042	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—DRD2—nicotine dependence	3.1e-05	0.000412	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—OPRM1—nicotine dependence	3.07e-05	0.000408	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—DRD2—nicotine dependence	3.05e-05	0.000405	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—DRD2—nicotine dependence	2.94e-05	0.00039	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—WASF2—nicotine dependence	2.78e-05	0.000369	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—WASF1—nicotine dependence	2.67e-05	0.000354	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—OPRM1—nicotine dependence	2.4e-05	0.000318	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—DRD2—nicotine dependence	2.36e-05	0.000313	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—DRD2—nicotine dependence	2.29e-05	0.000304	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—DRD2—nicotine dependence	2.22e-05	0.000295	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD2—nicotine dependence	1.74e-05	0.00023	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP2A7—nicotine dependence	1.24e-05	0.000165	CbGpPWpGaD
